Perioperative Antibiotics in Thoracic Surgery

Thoracic Surgery Clinics

Volumn 22, Issue 1, 2012, Pages 35-45

  Chang, Stephanie H ^a   Krupnick, Alexander S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

General thoracic surgery; Perioperative antibiotics; Postoperative infection; Transplantation

Indexed keywords

ACICLOVIR; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFALEXIN; CEFALORIDINE; CEFALOTIN; CEFAMANDOLE; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFUROXIME; CEPHALOSPORIN; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; GANCICLOVIR; MEROPENEM; METICILLIN; METRONIDAZOLE; PENICILLIN G; PENTAMIDINE; PIPERACILLIN PLUS TAZOBACTAM; PLACEBO; SULTAMICILLIN; UNINDEXED DRUG; VALGANCICLOVIR; VANCOMYCIN;

ABSCESS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ASPERGILLOSIS; BRONCHOPLEURAL FISTULA; BURKHOLDERIA CEPACIA; CANDIDA; CANDIDIASIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; EMPYEMA; ESOPHAGUS SURGERY; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SURGERY; GRAM NEGATIVE BACTERIUM; GYNECOLOGIC SURGERY; HAND WASHING; HEAD AND NECK SURGERY; HEART SURGERY; HIP FRACTURE; HUMAN; INSTRUMENT STERILIZATION; LUNG RESECTION; LUNG TRANSPLANTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOSIS; PENICILLIN ALLERGY; PERIOPERATIVE PERIOD; PNEUMOCYSTOSIS; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PSEUDOMONAS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; REVIEW; SHORT COURSE THERAPY; SKIN SURGERY; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS HAEMOLYTICUS; STOMACH SURGERY; STREPTOCOCCUS MILLERI; STREPTOCOCCUS PNEUMONIAE; SURGICAL INFECTION; SURGICAL MORTALITY; THORAX SURGERY; TREATMENT DURATION; VIRUS INFECTION; WOUND DRESSING; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; HUMANS; PERIOPERATIVE CARE; SURGICAL WOUND INFECTION; THORACIC SURGICAL PROCEDURES;

EID: 81855192702     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2011.08.012     Document Type: Review

References (58)

1. Horan T.C., Gaynes T.P., Martone W.J., et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992, 13(10):606-608.
2. Beilman G.J., Dunn D.L., et al. Surgical infections. Schwartz's principles of surgery 2009, McGraw-Hill Professional, New York, Chapter 6. 9th edition. F.C. Brunicardi, D.K. Andersen, T.R. Billiar (Eds.).
3. Burke J.F. The effective period of preventive antibiotic action in experimental incision and dermal lesions. Surgery 1961, 50:161-168.
4. Bernard H.R., Cole W.R. The prophylaxis of surgical infection: the effect of prophylactic antimicrobial drugs on the incidence of infection following potentially contaminated operations. Surgery 1964, 56:151-159.
5. Brown J.W., Cooper N., Rambo W.M. Controlled prospective double-blind evaluation of a " prophylactic" antibiotic (cephaloridine) in surgery. Antimicrob Agents Chemother 1969, 9:421-423.
6. Allen J.L., Rampone J.F., Wheeless C.R. Use of a prophylactic antibiotic in elective major gynecologic operations. Obstet Gynecol 1972, 39:218-224.
7. Boyd R.J., Burke J.F., Colton T. A double-blind clinical trial of prophylactic antibiotics in hip fractures. J Bone Joint Surg Am 1973, 55:1251-1258.
8. Edwards F.H., Engelman R.M., Houck P., et al. The society of thoracic surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part I: duration. Ann Thorac Surg 2006, 81:397-404.
9. Kvale P., Ranga V., Kopacz M., et al. Pulmonary resection. South Med J 1977, 70:64-69.
10. Truesdale R., D'Alessandri R., Manuel V., et al. Antimicrobial vs placebo prophylaxis in noncardiac thoracic surgery. JAMA 1979, 241:1254-1256.
11. Cameron J., Imbembo A., Keiffer R., et al. Prospective clinical trial of antibiotics for pulmonary resection. Surg Gynecol Obstet 1981, 152:156-158.
12. Ilves R., Cooper J., Todd T., et al. Prospective, randomized, double-blind study using prophylactic cephalothin for major, elective, general thoracic operations. J Thorac Cardiovasc Surg 1981, 81:813-817.
13. Frimodt-Møller N., Ostri P., Pedersen I., et al. Antibiotic prophylaxis in pulmonary surgery: a double- blind study of penicillin versus placebo. Ann Surg 1982, 195:444-450.
14. Aznar R., Mateu M., Miro J., et al. Antibiotic prophylaxis in non-cardiac thoracic surgery: cefazolin versus placebo. Eur J Cardiothorac Surg 1991, 5:515-518.
15. American Society of Health-System Pharmacists Commission on Therapeutics ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 1999, 56:1839-1888.
16. Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999, 20:247-280.
17. DiPiro J.T., Cheung R.P., Bowden T.A., et al. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg 1986, 152:552-559.
18. McDonald M., Grabsch E., Marshall C., et al. Single versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg 1998, 68:388-396.
19. Olak J., Jeyasingham K., Forrester-Wood C., et al. Randomized trial of one-dose versus six-dose cefazolin prophylaxis in elective general thoracic surgery. Ann Thorac Surg 1991, 51:956-958.
20. Wertzel H., Swoboda L., Joos-Wurtemberger A., et al. Perioperative antibiotic prophylaxis in general thoracic surgery. Thorac Cardiovasc Surg 1992, 40:326-329.
21. Bernard A., Pillett M., Goudet P., et al. Antibiotic prophylaxis in pulmonary surgery: a prospective randomized double-blind trial of flash cefuroxime versus forty-eight-hour cefuroxime. J Thorac Cardiovasc Surg 1994, 107:896-900.
22. Stone H.H., Hooper C.A., Kolb L.D., et al. Antibiotic prophylaxis in gastric, biliary and colonic surgery. Ann Surg 1976, 184:443-452.
23. Nichols R.L., Smith J.W., Muzik A.C., et al. Preventative antibiotic usage in traumatic thoracic injuries requiring closed tube thoracostomy. Chest 1994, 106:1493-1498.
24. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther 1999, 41:75-80.
25. Engelman R., Shahian D., Shemin R., et al. The society of thoracic surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II: antibiotic choice. Ann Thorac Surg 2007, 83:1569-1576.
26. Turna A., Kutlu C., Ozalp T., et al. Antibiotic prophylaxis in elective thoracic surgery: cefuroxime versus cefepime. Thorac Cardiovasc Surg 2003, 51:84-88.
27. Classen D.C., Evans R.S., Pestotnik S.L., et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992, 326:281-286.
28. Lewis R.T., Allan C.M., Goodall R.G., et al. Cefamandole in gastroduodenal surgery: a controlled, prospective, randomized, double-blind study. Can J Surg 1982, 25:561-563.
29. Nichols T.L., Webb W.R., Jones J.W., et al. Efficacy of antibiotic prophylaxis in high risk gastroduodenal operations. Am J Surg 1982, 143:94-98.
30. Rotman N., Hay J.M., Lacaine F., et al. Prophylactic antibiotherapy in abdominal surgery. First- vs third-generation cephalosporins. Arch Surg 1989, 124:323-327.
31. Howard J.M., Barker W.F., Culbertson W.R., et al. Postoperative wound infections: the influence of ultraviolet irradiation of the operating room and of various other factors. Ann Surg 1964, 160:1-192.
32. Culver D.H., Horan T.C., Gaynes R.P., et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 1991, 91:152S-157S.
33. Stone H.H., Haney B.B., Kolb L.D., et al. Prophylactic and preventive antibiotic therapy: timing, duration and economics. Ann Surg 1979, 189:691-699.
34. Lewis R.T., Goodall R.G., Marien B., et al. Efficacy and distribution of single-dose preoperative antibiotic prophylaxis in high-risk gastroduodenal surgery. Can J Surg 1991, 34:117-122.
35. Gatehouse D., Dimock F., Burdon D.W., et al. Prediction of wound sepsis following gastric operations. Br J Surg 1978, 65:551-554.
36. Lewis R.T., Allan C.M., Goodall R.G., et al. Discriminate use of antibiotic prophylaxis in gastroduodenal surgery. Am J Surg 1979, 138(5):640-643.
37. Hosenpud J.D., Bennett L.E., Keck B.M., et al. The registry of the International Society for Heart and Lung Transplantation: sixteenth official report - 1999. J Heart Lung Transplant 1999, 18:611-626.
38. Alexander B.D., Tapson V.F. Infectious complications of lung transplantation. Transpl Infect Dis 2001, 3(3):128-137.
39. Husain S., Zaldonis D., Kusne S., et al. ariation in antifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis 2006, 8(4):213-218.
40. Dauber J.H., Paradis I.L., Dummer J.S. Infectious complications in pulmonary allograft recipients. Clin Chest Med 1990, 11(2):291-308.
41. Duarte A.G., Lick S. Perioperative care of lung transplant patients. Chest Surg Clin N Am 2002, 12:397-416.
42. Smyth T.L., Scott J.P., Borysiewicz L.K., et al. Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment. J Infect Dis 1991, 164(6):1045-1050.
43. Duncan S.R., Grgurich W.F., Iacono A.T., et al. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med 1994, 150(1):146-152.
44. Meyers B.F., Lynch J., Trulock E.P., et al. Lung transplantation: a decade of experience. Ann Surg 1999, 230(3):362-370.
45. Calvo V., Borro J.M., Morales P., et al. Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group. Chest 1999, 115(5):1301-1304.
46. Morino E., Gallagher J.C. Prophylactic antifungal agents used after lung transplantation. Ann Pharmacother 2010, 44:546-556.
47. Reichenspurner H., Gamberg P., Nitschke M., et al. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. Transplant Proc 1997, 29:627-628.
48. Minari A., Husni R., Avery R.K., et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transpl Infect Dis 2002, 4:195-200.
49. Husain S., Paterson D.L., Studer S., et al. Voriconazole prophylaxis in lung transplant recipients. Am J Transplant 2006, 6:3008-3016.
50. Ramsey B.W., Dorkin H.L., Eisenberg J.D., et al. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 1993, 328(24):1740-1746.
51. Valerius N.H., Koch C., Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991, 338(8769):725-726.
52. Bauldoff G.S., Nunley D.R., Manzetti J.D., et al. Use of aerosolized colistin sodium in cystic fibrosis patients awaiting lung transplantation. Transplantation 1997, 64(5):748-752.
53. Davies C.W., Gleeson F.V., Davies R.J. BTS guidelines for management of pleural infection. Thorax 2003, 58:ii18-ii28.
54. Alfageme I., Munoz F., Pena N., et al. Empyema of the thorax in adults. Etiology, microbiologic findings, and management. Chest 1993, 103:839-843.
55. Sherman M.M., Subramanian V., Berger R.L. Management of thoracic empyema. Am J Surg 1977, 133:474-479.
56. Hughes C.E., Van Scoy R.E. Antibiotic therapy of pleural empyema. Semin Respir Infect 1991, 6:94-102.
57. Taryle D.A., Good J.T., Morgan E.J., et al. Antibiotic concentrations in human parapneumonic effusions. Antimicrob Agents Chemother 1981, 7:171-177.
58. Huchon G., Woodhead M. Guidelines for management of adult community-acquired lower respiratory tract infections. European Study on Community-acquired Pneumonia (ESOCAP) Committee. Eur Respir J 1998, 11:986.